Empowered Patient Podcast

Ram Sahasranam is the Co-Founder and President of Fold Health and building primary care delivery systems that focus on the experience of the physician and the patient. Fold has designed an operating system that works for primary care providers and their patients and folds all of the existing healthcare elements around these two individuals and their care delivery concerns. Sitting on top of existing electronic health record systems, Fold integrates legacy systems to bring real innovation to an environment originally built as a billing solution.

Ram explains, "What we saw during the pandemic was the lack of primary care being at the center of care where America is concerned. If you look at how we designed our system, primary care was supposed to be the hub around which the spokes of healthcare were supposed to function."

"But unfortunately, primary care was being looked at as traffic cops for specialty care. So we want to solve for that because about 80% of all care can actually be delivered at the primary care level. But the tools do not exist because the tools were built in a very different era. So, we've taken a complete full-stack approach so that where the providers and patients are concerned, the experience becomes the most critical aspect. Where automation is concerned, contextual intelligence becomes the most critical aspect to ensure that qualitative care delivery is happening across the continuum for the provider and the patient."

@FoldHealth #FoldHealth #Telehealth #HealthTech #Healthcare #PrimaryCare #DPC #DirectPrimaryCare #CRM

fold.health

Listen to the podcast here

Ram Sahasranam is the Co-Founder and President of Fold Health and building primary care delivery systems that focus on the experience of the physician and the patient. Fold has designed an operating system that works for primary care providers and their patients and folds all of the existing healthcare elements around these two individuals and their care delivery concerns. Sitting on top of existing electronic health record systems, Fold integrates legacy systems to bring real innovation to an environment originally built as a billing solution.

Ram explains, "What we saw during the pandemic was the lack of primary care being at the center of care where America is concerned. If you look at how we designed our system, primary care was supposed to be the hub around which the spokes of healthcare were supposed to function."

"But unfortunately, primary care was being looked at as traffic cops for specialty care. So we want to solve for that because about 80% of all care can actually be delivered at the primary care level. But the tools do not exist because the tools were built in a very different era. So, we've taken a complete full-stack approach so that where the providers and patients are concerned, the experience becomes the most critical aspect. Where automation is concerned, contextual intelligence becomes the most critical aspect to ensure that qualitative care delivery is happening across the continuum for the provider and the patient."

@FoldHealth #FoldHealth #Telehealth #HealthTech #Healthcare #PrimaryCare #DPC #DirectPrimaryCare #CRM

fold.health

Download the transcript here

Jill Pellegrino is the VP of Recruitment and RWE at CVS Health Clinical Trial Services. Real-world evidence uses data collected in a real-world setting and can supplement data collected in the controlled setting of a clinical trial. It could be used to measure safety outcomes, the efficacy of treatments, or behaviors that impact the quality of life.

Jill explains, "Most parties that are relying on real-world data are pulling it from claims or medical records. And this data is often de-identified, but it can be patchy because it needs to be pulled from multiple sources. At CVS, we have access to clinical data that's more cohesive because it spans across our different businesses and brings in data from payer, pharmacy, and provider in one set."

"But we don't just rely on clinical data when we're thinking about real-world evidence. We invite our customer community to participate directly in research opportunities, which allows us to gather insights directly from the patients. That patient voice is really helpful in illuminating variables that may be impacting their healthcare decisions as well as the disease burden impact on their daily lives."

@CVSHealth #RWE #RealWorldEvidence #RWD #RealWorldData #ClinicalTrial

CVSHealth.com

Listen to the podcast here

Jill Pellegrino is the VP of Recruitment and RWE at CVS Health Clinical Trial Services. Real-world evidence uses data collected in a real-world setting and can supplement data collected in the controlled setting of a clinical trial. It could be used to measure safety outcomes, the efficacy of treatments, or behaviors that impact the quality of life.

Jill explains, "Most parties that are relying on real-world data are pulling it from claims or medical records. And this data is often de-identified, but it can be patchy because it needs to be pulled from multiple sources. At CVS, we have access to clinical data that's more cohesive because it spans across our different businesses and brings in data from payer, pharmacy, and provider in one set."

"But we don't just rely on clinical data when we're thinking about real-world evidence. We invite our customer community to participate directly in research opportunities, which allows us to gather insights directly from the patients. That patient voice is really helpful in illuminating variables that may be impacting their healthcare decisions as well as the disease burden impact on their daily lives."

@CVSHealth #RWE #RealWorldEvidence #RWD #RealWorldData #ClinicalTrial

CVSHealth.com

Download the transcript here

Dr. Mukul Mehra is the Chief Medical Officer and Co-Founder of IllumiCare and firmly believes that cost transparency should be given to physicians so that hard clinical decisions can put the cost of treatment into perspective. By providing real-time data, IllumiCare is influencing clinician behavior to reduce waste, lower costs and improve decisions about appropriate treatments.

Mukul explains, "So IllumiCare is essentially bringing in all of these constructs of different points in a patient's care journey in the inpatient setting, giving a cost definition to what that treatment is costing, and getting down to a real true cost. Then understanding that at different points in a treatment plan, that certainly there may not be proper adjudication. But if we don't start off with cost transparency, then we're not going to really get to define the cost of waste."

"When you aggregate data and make it retrospect, it tends to have very little influence or impact on physician practice patterns. And in the end, IllumiCare is a behavioral change company. And we want to change behavior by reducing costs, but we want to reduce costs when you can decelerate good therapy when you now only need a pretty good drug because that's good enough. And so the nuances of all of that are only going to occur when you give this information at the point-of-care, contextually, in real-time. And that's occurring over the electronic medical record for many of us in that data assimilation and review mode."

"It's most directly designed to influence physician/clinician behavior. It's EMR agnostic. It grabs EMR data. It works in harmony with any electronic medical record. And it has really three ways to influence providers. One, it's point-of-care. Two, it can detect what a provider's wasteful tendencies are. Of course, the provider is the ultimate adjudicator. It detects the context of the patient and the provider's prior behaviors and what's going on with the current patient. And it can nudge, preemptively, a suggestion, sort of a digital, hey, tap on the shoulder, but it doesn't stop or interrupt the physician's workflow."

#IllumiCare #healthit #ehr #emr #hospitalpayers #payers #hospitals #patientcosts #patientprotection #costtransparency #lengthofstay #stewardship #patientcare #healthcaresystems

IllumiCare.com

Listen to the podcast here

Dr. Mukul Mehra is the Chief Medical Officer and Co-Founder of IllumiCare and firmly believes that cost transparency should be given to physicians so that hard clinical decisions can put the cost of treatment into perspective. By providing real-time data, IllumiCare is influencing clinician behavior to reduce waste, lower costs and improve decisions about appropriate treatments.

Mukul explains, "So IllumiCare is essentially bringing in all of these constructs of different points in a patient's care journey in the inpatient setting, giving a cost definition to what that treatment is costing, and getting down to a real true cost. Then understanding that at different points in a treatment plan, that certainly there may not be proper adjudication. But if we don't start off with cost transparency, then we're not going to really get to define the cost of waste."

"When you aggregate data and make it retrospect, it tends to have very little influence or impact on physician practice patterns. And in the end, IllumiCare is a behavioral change company. And we want to change behavior by reducing costs, but we want to reduce costs when you can decelerate good therapy when you now only need a pretty good drug because that's good enough. And so the nuances of all of that are only going to occur when you give this information at the point-of-care, contextually, in real-time. And that's occurring over the electronic medical record for many of us in that data assimilation and review mode."

"It's most directly designed to influence physician/clinician behavior. It's EMR agnostic. It grabs EMR data. It works in harmony with any electronic medical record. And it has really three ways to influence providers. One, it's point-of-care. Two, it can detect what a provider's wasteful tendencies are. Of course, the provider is the ultimate adjudicator. It detects the context of the patient and the provider's prior behaviors and what's going on with the current patient. And it can nudge, preemptively, a suggestion, sort of a digital, hey, tap on the shoulder, but it doesn't stop or interrupt the physician's workflow."

#IllumiCare #healthit #ehr #emr #hospitalpayers #payers #hospitals #patientcosts #patientprotection #costtransparency #lengthofstay #stewardship #patientcare #healthcaresystems

IllumiCare.com

Download the transcript here

Matty Culbreth-Notaro is the Chief Operations Officer at ObvioHealth and developing a new model for virtual decentralized clinical trials. Accelerated by the pandemic, there is widespread global acceptance of DCT. This digital solution and mobile app are an efficient approach to identifying and recruiting trial participants and significantly increasing trial completion rates.

Matty elaborates, "When I joined ObvioHealth, I had been in the industry for almost 30 years, I didn't know that it would actually work as well as it has. And now, being with Obvio for five years, I've seen the huge impact it's made, the technology has made to our patients, to our industry in general. And it's just been a great way for us to marry the tech and the service and leverage all the technological innovations that we have to tackle those inefficiencies in our industry."

"Our technology has built-in intelligence that it's able to say, well, you qualify, or you don't qualify, at least from the pre-screening questionnaire. And then, we send them, if they do qualify, a link to the app to download onto their smartphone. From there, we onboard them. We'll do the consenting process right on the phone. We'll ask them all the screening questionnaires right there. And then they're assigned to a virtual site team that's going to help them along the way. They're using their own smartphones to complete all of the study-related visits or study-related procedures."

"Now, not every trial can be done 100% in a decentralized way. Some trials have to be done with still a brick-and-mortar site involved in the process. And for that, that's called a hybrid model. We support that as well, so the participant can go to the office for some visits, but they don't have to go to the office for all the visits like they used to. And in many cases, none of this has to be done at the office anymore. It can be done remotely."

#ClinicalTrials #ObvioHealth #DecentralizedTrials #VirtualTrials #DCT #PatientEngagement #PatientCentricity #HybridClinicalTrials #DecentralizedClinicalTrials #DCTs #PatientAdherence #PatientCompliance #ClinicalResearch #RareDiseases

obviohealth.com

Listen to the podcast here

Matty Culbreth-Notaro is the Chief Operations Officer at ObvioHealth and developing a new model for virtual decentralized clinical trials. Accelerated by the pandemic, there is widespread global acceptance of DCT. This digital solution and mobile app are an efficient approach to identifying and recruiting trial participants and significantly increasing trial completion rates.

Matty elaborates, "When I joined ObvioHealth, I had been in the industry for almost 30 years, I didn't know that it would actually work as well as it has. And now, being with Obvio for five years, I've seen the huge impact it's made, the technology has made to our patients, to our industry in general. And it's just been a great way for us to marry the tech and the service and leverage all the technological innovations that we have to tackle those inefficiencies in our industry."

"Our technology has built-in intelligence that it's able to say, well, you qualify, or you don't qualify, at least from the pre-screening questionnaire. And then, we send them, if they do qualify, a link to the app to download onto their smartphone. From there, we onboard them. We'll do the consenting process right on the phone. We'll ask them all the screening questionnaires right there. And then they're assigned to a virtual site team that's going to help them along the way. They're using their own smartphones to complete all of the study-related visits or study-related procedures."

"Now, not every trial can be done 100% in a decentralized way. Some trials have to be done with still a brick-and-mortar site involved in the process. And for that, that's called a hybrid model. We support that as well, so the participant can go to the office for some visits, but they don't have to go to the office for all the visits like they used to. And in many cases, none of this has to be done at the office anymore. It can be done remotely."

#ClinicalTrials #ObvioHealth #DecentralizedTrials #VirtualTrials #DCT #PatientEngagement #PatientCentricity #HybridClinicalTrials #DecentralizedClinicalTrials #DCTs #PatientAdherence #PatientCompliance #ClinicalResearch #RareDiseases

obviohealth.com

Download the transcript here

Dr. Paul Sherman is the Chief Medical Officer of the Community Health Plan of Washington, the only nonprofit managed care organization for Medicaid in Washington state. They have also expanded into offering Medicare Advantage plans and providing a public/private low-cost insurance option for low-income people who do not qualify for Medicaid. Paul is enthusiastic about the new benefits that have been added to provide alternative approaches to healthcare that are less invasive and have better options than opioids for pain management.

Paul explains, "Treatments that we're offering with this new benefit are a package of chiropractic, acupuncture, and massage therapy. So those traditional plans have offered services on a medical necessity or another basis. Still, we're trying to offer them in a much more patient-centered way where it's much easier for them to access it, to access the treatments that are important to them."

"We're starting with those three benefits, but as we work with our members across the state and listen to their needs, we're talking to various populations about what other alternative therapies we should consider offering. We're talking to Native American tribes and our Mexican communities to really understand if there are other treatments that are important to them that we should think about adding to this benefit."

@MyCHPW #CommunityHealthPlanofWashington #AlternativeTherapies #Medicaid #Medicare #Acupuncture #Chiropractic #MassageTherapy #PatientCentered

chpw.com

Listen to the podcast here

Dr. Paul Sherman is the Chief Medical Officer of the Community Health Plan of Washington, the only nonprofit managed care organization for Medicaid in Washington state. They have also expanded into offering Medicare Advantage plans and providing a public/private low-cost insurance option for low-income people who do not qualify for Medicaid. Paul is enthusiastic about the new benefits that have been added to provide alternative approaches to healthcare that are less invasive and have better options than opioids for pain management.

Paul explains, "Treatments that we're offering with this new benefit are a package of chiropractic, acupuncture, and massage therapy. So those traditional plans have offered services on a medical necessity or another basis. Still, we're trying to offer them in a much more patient-centered way where it's much easier for them to access it, to access the treatments that are important to them."

"We're starting with those three benefits, but as we work with our members across the state and listen to their needs, we're talking to various populations about what other alternative therapies we should consider offering. We're talking to Native American tribes and our Mexican communities to really understand if there are other treatments that are important to them that we should think about adding to this benefit."

@MyCHPW #CommunityHealthPlanofWashington #AlternativeTherapies #Medicaid #Medicare #Acupuncture #Chiropractic #MassageTherapy #PatientCentered

chpw.org

Download the transcript here